sample_id,Sample coverage,Tumor Purity,age_at_diagnosis,age_at_seq_reported_years,ethnicity,exon_number,gender,metastic_site,mitotic_rate,msi_score,msi_type,mutated_genes,note,order,os_months,os_status,patient_id,ped_ind,pre_therapy_group,primary_site,primary_site_group,race,recurrence_free_months,recurrence_status,sample_type,stage_at_diagnosis,tmb_nonsynonymous,treatment,treatment_details,treatment_duration_days,treatment_response,tumor_size,variant_type
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.04,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.218310601,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.04,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.218310601,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.76,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.76,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.109155301,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.218310601,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.218310601,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.33,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.33,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.33,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.33,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.33,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.2,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.46,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.872318186,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.46,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.872318186,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.46,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.872318186,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.46,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.872318186,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.46,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.872318186,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.46,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.872318186,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.61,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.61,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.61,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.61,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,3.327465902,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.61,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,3.327465902,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.61,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,3.327465902,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.35,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,1.109155301,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.35,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.218310601,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.218310601,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.85,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0666666666667,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.82,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.82,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.82,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,2.218310601,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.82,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,2.218310601,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.64,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.64,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0666666666667,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.64,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.64,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0666666666667,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.218310601,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.218310601,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.109155301,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0333333333333,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.42,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,3.327465902,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.42,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,3.327465902,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.42,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,3.327465902,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.42,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.42,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.42,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.54,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.327465902,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.54,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.54,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.54,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.54,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.327465902,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.327465902,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.54,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,2.218310601,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,2.218310601,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.97,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0333333333333,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0333333333333,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0333333333333,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0333333333333,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.957439395,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.957439395,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.44,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.44,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.44,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.44,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.44,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.44,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.44,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.44,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.44,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.44,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.44,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.44,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.44,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.44,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.44,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.44,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.74648481,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.44,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.44,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.44,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.44,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.44,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.44,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.44,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.44,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.44,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.44,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.44,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.44,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.44,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.44,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.44,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.44,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.533333333333,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.68,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.68,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.68,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.68,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.68,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.68,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.218310601,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.68,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.68,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.68,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.218310601,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.68,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.68,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.68,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.17,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.17,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.17,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.17,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.17,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.17,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.17,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.17,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.17,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.17,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.17,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.17,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.133333333333,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.84,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,4.323490475,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.84,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,4.323490475,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.84,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,4.323490475,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.84,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,4.323490475,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.84,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,4.323490475,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.11,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.978719698,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.11,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0333333333333,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.1,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.1,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.109155301,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.21,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.21,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.21,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.21,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.21,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.21,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.21,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.21,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.58,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.58,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.978719698,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.51,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.51,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.51,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.51,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.51,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.51,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.51,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.936159093,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.51,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.936159093,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.936159093,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.51,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.25,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.25,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.25,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.25,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.936159093,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.25,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.25,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.936159093,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.25,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.25,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.25,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.25,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.25,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.936159093,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.25,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.09,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.09,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.09,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.978719698,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.49,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.96,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.46104171,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.96,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.46104171,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.96,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.46104171,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.08,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.08,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.08,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.08,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.95,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.95,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.95,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.95,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.95,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.95,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.95,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.95,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.95,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.95,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.95,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.95,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.49,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.49,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0333333333333,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.49,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.978719698,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.25,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.1,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.25,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.1,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.25,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.1,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.14,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.18818857,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.14,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.18818857,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.14,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.18818857,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.14,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.18818857,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.14,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.18818857,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.14,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.18818857,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.87,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.87,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.87,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.87,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.87,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.87,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.87,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.1,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.53,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.72939619,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.53,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.72939619,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.936159093,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.936159093,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.17,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.17,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.936159093,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.17,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.17,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.17,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.17,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.17,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.17,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.17,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.1,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.864698095,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.19,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.19,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.19,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.19,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.42,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.42,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.42,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.42,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.71,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.71,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.71,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.71,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,1.03,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.936159093,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,1.03,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,1.03,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,1.03,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,1.03,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.936159093,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,1.03,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.936159093,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.17,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.17,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.91,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.91,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.91,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.91,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.91,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.91,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.91,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.91,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.91,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.91,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.91,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.91,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.91,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.91,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.91,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.91,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.77,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.77,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.77,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.77,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.77,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.41,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.41,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.41,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.41,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.45,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.45,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.45,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.45,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.45,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.45,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.45,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.45,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.45,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.45,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.72939619,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.72939619,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0666666666667,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0666666666667,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.43,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.43,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.43,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.43,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.89,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.89,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.89,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.18,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.820347237,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.18,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.46,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.56,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.56,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.56,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.56,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.56,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.56,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.56,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.56,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.58,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.58,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.957439395,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.58,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.957439395,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.58,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0333333333333,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0333333333333,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0333333333333,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0333333333333,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.09,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.957439395,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.09,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.957439395,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.53,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.978719698,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.58,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.58,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.62,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.72939619,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.62,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.72939619,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.59,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.59,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.59,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.59,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.59,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.59,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.59,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.59,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.59,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.59,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.59,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.59,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.09,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.09,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.09,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.09,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.05,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0333333333333,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.05,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.978719698,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.96,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.96,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.96,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.96,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.35,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.35,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.35,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.35,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.35,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.323490475,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.17,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.936159093,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.17,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.936159093,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.17,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.936159093,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.17,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.1,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.17,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.1,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.17,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.1,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.08,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.08,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0333333333333,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,2.01,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,2.01,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,2.01,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.01,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.01,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.01,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.01,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.01,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.01,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.01,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.01,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.01,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.01,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.01,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.01,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.1,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.08,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.957439395,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.957439395,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.08,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.08,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.67,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.67,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0666666666667,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.67,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.67,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0666666666667,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.67,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.67,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.49,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.49,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.49,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.49,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.85,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,5.18818857,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.85,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,5.18818857,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.85,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,5.18818857,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.85,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,5.18818857,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.85,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,5.18818857,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.85,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,5.18818857,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.64,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0333333333333,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.64,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0333333333333,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.64,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.978719698,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.37,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.37,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.37,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.37,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.81,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.81,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.81,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.957439395,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.81,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0666666666667,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.53,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.53,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.53,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.53,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.53,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.1,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.53,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.35,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.35,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.35,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.29,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.29,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.29,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.29,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.29,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.29,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.29,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.29,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.29,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.29,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.29,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.29,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.29,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.133333333333,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.95,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.95,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.95,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.957439395,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.95,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.957439395,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.95,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.95,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.95,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.95,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.95,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.95,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.95,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.95,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.9,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.9,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0333333333333,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.9,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.9,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0333333333333,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.02,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.02,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.02,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.02,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.02,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.02,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.02,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.872318186,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.872318186,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.872318186,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.872318186,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.872318186,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.02,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.872318186,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.02,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.2,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.87,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.87,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.87,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.87,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.87,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.1,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.87,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.1,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.46,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.46,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.46,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,2.594094285,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.27,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.27,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.27,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.27,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.27,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.27,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.27,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.27,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.27,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.27,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.27,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.27,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0666666666667,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.27,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.957439395,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.27,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.957439395,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.14,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.14,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.14,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.14,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.14,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.14,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.14,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.14,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.14,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.14,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.14,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.14,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.14,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.14,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.14,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.14,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.14,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.14,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.14,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.14,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.91487879,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.26,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0333333333333,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.26,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0333333333333,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.26,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.978719698,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.28,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.28,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0666666666667,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.28,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.28,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.957439395,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.95,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.95,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.95,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.95,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.95,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.95,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.95,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.95,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.95,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.95,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.936159093,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.95,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.95,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.95,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.95,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.95,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.1,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.56,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.56,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0333333333333,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.56,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0333333333333,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.56,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0333333333333,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.56,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.32,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.32,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.32,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.32,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.32,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.32,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.32,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.32,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.32,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.893598488,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.32,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.166666666667,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.14,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.978719698,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.14,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.2725,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.63,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.72939619,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.63,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.72939619,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.18,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.18,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.18,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.594094285,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.18,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.1,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.18,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.594094285,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.18,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.594094285,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.13,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.864698095,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.13,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0333333333333,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
